Iradimed (IRMD) Shares Outstanding (Diluted Average) (2019 - 2026)

Iradimed (IRMD) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $12.9 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $12.9 million, changed 0.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (changed 0.34% YoY), and the FY2024 annual result was $12.8 million, changed 0.48% from the prior year.
• Shares Outstanding (Diluted Average) held at $12.9 million in Q1 2026 per IRMD's latest filing, from $12.8 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $12.9 million in Q1 2026 and troughed at $12.6 million in Q2 2022.
• A 5-year average of $12.7 million and a median of $12.7 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) grew 0.78% in 2023, then increased 0.21% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $12.6 million in 2022, then climbed by 0.69% to $12.7 million in 2023, then grew by 0.48% to $12.8 million in 2024, then climbed by 0.46% to $12.8 million in 2025, then climbed by 0.22% to $12.9 million in 2026.
• Business Quant data shows IRMD's Shares Outstanding (Diluted Average) at $12.9 million in Q1 2026, $12.8 million in Q3 2025, and $12.8 million in Q2 2025.